FDA Drug Topics: FDA Drug Information Resources and Applicability to Health Care Professionals
February 18, 2020
FDA
This series of educational webinars is designed to aid physicians, physician assistants, nurses, pharmacists, pharmacy technicians, certified public health professionals, other health care professionals, and students, to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety.
This webinar will provide an orientation to drug information resources on the FDA website including drug shortages, drug recalls, adverse event reporting, and product labeling. Health care professionals will learn how these drug information resources can be used in their practice to locate information that improves patient care.
- CDER Division of Drug Information Website: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/cder-division-drug-information.
- Drugs@FDA: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm.
- MedWatch: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.
- Drug Shortages: https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages.
- Recalls, Market Withdrawals, & Safety Alerts: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts.
- Drug Safety Communications: https://www.fda.gov/drugs/drug-safety-and-availability/drug-safety-communications.
- Explain how to utilize FDA’s drug information, medication safety resources, and regulatory guidance, to improve delivery of patient care and optimize outcomes.
- Describe and inform health care providers of recent labeling, policy and regulatory changes which would impact prescribing and medication management to optimize patient care.
- Identify drug information resources for HCPs to stay informed on FDA actions, decisions and initiatives.
- Demonstrate the use and application of these resources for common health-related inquiries.
- Discuss non-traditional drug information resources – social media, podcasts, and videos.
This activity is intended for physicians, pharmacists, pharmacy technicians, nurses, and physician assistants.
Lecture 1 February 18, 2020
Time | Topic | Speaker |
---|---|---|
1:00 - 2:00 PM EST | FDA Drug Information Resources and Applicability to Health Care Professionals | Sandra Bai, PharmD |
Physicians, physician assistants, pharmacists, nurses, pharmacist techs, and those claiming non-physician CME: participants must attest to their attendance and complete the final activity evaluation via the CE Portal (ceportal.fda.gov). For multi-day activities, participants must attest to their attendance and complete the faculty evaluation each day. Final activity evaluations must be completed within two weeks after the activity - no exceptions.
Attention Pharmacists and Pharmacy Techs: Failure to provide your correct NABP AND Date of Birth information, in the required format, may result in the loss of credit for this activity. NABP profile number should be the 6-7 digit profile number assigned by the CPE Monitor and your birth date should be in the MMDD format (e.g. 0721) Do not provide your pharmacy license number. Please click the "My Account" tab and then navigate to "Edit Contact Information" to verify that your information is correct.
Attendees have 14 days from the last day of the activity to log in, complete the required evaluation(s) and attest to your attendance to claim credit.Physicians, physician assistants, and nurses may then view/print statement of credit. Pharmacists should log into the CPE monitor 8 weeks after the last session of the activity to obtain their CE credit.
Faculty
- Bai, Sandra, PharmD, Drug Information Specialist, FDA - nothing to disclose
Planning Committee
- Burke, Kara, PharmD, Team Leader/Pharmacist, FDA/CDER/OCOMM/DDI - nothing to disclose
- Cao, Christian, MPAS, PA-C, Cross-Discipline Safety Advisor, FDA/CDER/OSE/OPE - nothing to disclose
- De Fronzo, Kimberly, RPh, MS, MBA, Consumer Safety Officer, FDA/CDER/OCOMM/DDI - nothing to disclose
- Kapoor, Rama, MD, Senior Physician, FDA - nothing to disclose
- Navin, Lesley, RN, MSN, Consumer Safety Officer, FDA/CDER/DDI - nothing to disclose
- Nguyen-Chu, Thanh, PharmD, Pharmacist, FDA/CDER/OCOMM/DDI - Disclosure not received.
CE Consultation and Accreditation Team
- Lisa Thompson, MSHA, MBA, CE Consultant, FDA/CDER/OEP/DLOD - nothing to disclose
- Zawalick, Karen, CE Team Leader, FDA/CDER/OEP/DLOD - nothing to disclose
Registration is complimentary; therefore refunds are not applicable.